These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7035790)

  • 1. [Heparin, streptokinase or surgical therapy in manifest thromboembolic diseases].
    Bruhn HD
    Med Welt; 1982 Jan; 33(2):62-5. PubMed ID: 7035790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current data on diagnosis and treatment of thromboembolic states].
    Zosin P; Roth L
    Med Interna (Bucur); 1972 Aug; 24(8):947-58. PubMed ID: 5080893
    [No Abstract]   [Full Text] [Related]  

  • 4. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
    Gross R
    Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic fibrinolysis].
    Straub PW
    Schweiz Med Wochenschr; 1973 May; 103(20):753-7. PubMed ID: 4702993
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of thromboembolic complications and management of acute pulmonary embolism].
    Ludwig H
    Munch Med Wochenschr; 1966 May; 108(19):1035-41. PubMed ID: 6014760
    [No Abstract]   [Full Text] [Related]  

  • 7. The René Leriche memorial lecture. The thrombo-embolic threat.
    Senning A
    J Cardiovasc Surg (Torino); 1985; 26(3):201-6. PubMed ID: 3997961
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of thromboembolism. Anticoagulants, thrombolytics, or surgical intervention?
    Kinasewitz GT; George RB
    Chest; 1984 Jul; 86(1):106-11. PubMed ID: 6428811
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulation.
    Chong BH
    Aust Fam Physician; 1996 Jan; 25(1):74-8. PubMed ID: 8607780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs in the treatment of thrombo-embolic diseases--Part II.
    Bouchier-Hayes D
    Ir Med J; 1983 Mar; 76(3):155-9. PubMed ID: 6345455
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of systemic streptokinase therapy in thromboembolism diseases].
    Hempel G; Schubert K; Fritz T; Platzbecker H; Reinhardt F; Wünschmann HJ
    Z Gesamte Inn Med; 1987 Apr; 42(8):205-9. PubMed ID: 3630288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A different focus on the current status of thrombolysis in pulmonary thromboembolism].
    Jerjes Sánchez C; Ramírez Rivera A; Gutiérrez Fajardo P; García Castillo A; Cantú Díaz F; Treviño Ortiz H; Villarreal Garza I
    Arch Inst Cardiol Mex; 1998; 68(2):166-80. PubMed ID: 9810361
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of pulmonary thromboembolism with small doses of streptokinase combined with heparin, nitroglycerin, and prednisolone].
    Ukolov VM; Iakovlev VA; Malygin VN; Matsnev AA; Severin SI; Mordik AI; Semenov AV
    Voen Med Zh; 1991 Oct; (10):29-32, 78; discussion 31-2. PubMed ID: 11411355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives: fibrinolysis and thrombolysis.
    Sherry S
    Thromb Diath Haemorrh Suppl; 1966; 20():1-12. PubMed ID: 5973051
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytic therapy with streptokinase.
    Chesterman CN; Biggs JC
    Med J Aust; 1970 Oct; 2(18):839-46. PubMed ID: 4923084
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: myocardial infarct. Randomized treatment using streptokinase].
    Valère PE; Guérot C; Castillo-Fenoy A; Laffay N; Tricot R
    Nouv Presse Med; 1975 Jan; 4(3):190. PubMed ID: 1093121
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolytic therapy of myocardial infarction: theory and clinical results.
    Ruegsegger P
    Angiologica; 1968; 5(2):136-45. PubMed ID: 5661002
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombolytic medication. Theoretical and practical aspects].
    Săvulescu V; Litarczek G
    Med Interna (Bucur); 1973 Sep; 25(9):1103-12. PubMed ID: 4792530
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
    Loo J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):172-94. PubMed ID: 50982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.